期刊文献+

^(99m)Tc-depreotide异构体的分离及鉴定

Isolation and identification of Syn and anti diastereomers of ^(99m)Tc-depreotide
原文传递
导出
摘要 目的分离、鉴定99mTc-depreotide异构体,并比较其生物活性。方法采用高压液相色谱仪分离99mTc-depreotide的一对顺式和反式异构体,采用质谱、CD光谱、1 H NMR分析异构体的结构特征,比较A549细胞对这对异构体的受体亲和性。结果高压液相色谱仪分离的顺式和反式异构体的含量比约为90∶10,顺式和反式异构体的分子质量均为1 469.5,均有不同的科顿效应;1 H NMR结果可显示二者的氨基酸序列和结构特征;顺式异构体的受体亲和性明显高于反式异构体(P<0.01)。结论 99mTc-depreotide存在顺式和反式异构体,且生物活性不同,在实际应用中应将2个异构体视作2个化合物。 Objective To isolate and identify Syn and anti diastereomers of ^99mTc-depreotide, and compare the biological activity. Methods Syn and anti distereomers of ^99mTc-depreotide were isolated by HPLC, and were identified by mass spectrograph, circular dichroism spectra and ^1H NMR. The binding affinities of Syn/anti ^99mTc-depreotide to SSTRs were evaluated with A549 cells. Results Syn/anti ^99mTc-depreotide products were observed by reversed phase HPLC in approximately 90 : 10 ratio. The mass of both distereomers was 1469. 5 corresponding to results of mass spectrograph. The different Cotton effect of the Syn/anti distereomers was observed. The amino acids and structural features of the Syn/anti distereomers were showed by 1 H NMR. The Syn diastereomer showed higher binding affinities than the anti distereomer in A549 cells (P〈0.01). Conclusion There are a pair of Syn and anti distereomers in ^99mTc depreotide, and the Syn distereomer has higher bioactivity than anti distereomer. In practical applications the two diastereomers chould be considered as two compounds.
出处 《中华实用诊断与治疗杂志》 2012年第11期1063-1066,共4页 Journal of Chinese Practical Diagnosis and Therapy
基金 上海市普陀区人民医院发展基金(RYK08F-01)
关键词 99mTc-depreotide 异构体 受体 分离 ^99mTc-depreotide diastereomer receptor isolation
  • 相关文献

参考文献12

  • 1夏伟,吕中伟,王国玉,侯仁花,蔡海东,袁雪宇.99Tcm标记depreotide及与肺腺癌A549细胞亲和性研究[J].国际放射医学核医学杂志,2010,34(4):193-197. 被引量:1
  • 2Xia W, Zhang X, Yu F, et al. Experimental study of ^99mTcdepreotide preparation and its affinity with A549 cell[J]. From Biosei, 2011,16 : 2527-2539.
  • 3Francesconi L C, Zheng Y, Bartis J, et al. Preparation and characterization of [99TcO] apcitide: a technetium labeled pcptide [J]. InorgChem,2004,43(9):2867-2875.
  • 4Cantorias M V, Howell R C, Todaro L, et al. MO tripeptidc diastereomers (M = 99/^99m Tc, Re): models to identify the structure of ^99mTc peptide targeted radiopharmaceuticals [J]. Inorg Chem,2007,46(18) :7326-7340.
  • 5夏伟,侯仁花,吕中伟,蔡海东,袁雪宇,胡海强.生长抑素类似物depreotide的合成与鉴定的实验研究[J].中华实用诊断与治疗杂志,2009,23(8):737-740. 被引量:6
  • 6Lee D Y, Li K C. Molecular theranostics: a primer for the imaging professional[J]. AJR Am J Roentgenol, 2011.197 ( 2 ) : 318-324.
  • 7Cyr J E, Nowotnik D P, Pan Y, et al. Technetium(V) oxo complexes of substituted propylene diamine dioxime (PnAO) ligands: water dependent interconversion between syn and anti isomers[J].Inorg Chem,2001,40(14):3555-3561.
  • 8JiangJ K, Shen M, Thomas C J, etal. Chiral kinase inhibitors [J]. Curt Top Med Chem,2011,11(7):800-809.
  • 9Torino D, Mollica A, Pinnen F, et al. Syntbesis and evaluation of new endomorphin 2 analogues containing (Z)-alpha, beta- didehydrophenylalanine ( Delta (Z) Phe) residues [J]. J Med Chem,2010,53(11):4550-4554.
  • 10沈玉梅.手性在放射性药物中的作用[J].核技术,2006,29(7):518-521. 被引量:1

二级参考文献60

  • 1顾锦法,刘新垣.癌症的靶向基因—病毒治疗[J].自然杂志,2005,27(2):85-89. 被引量:6
  • 2王秀娟,李险峰.生长抑素受体肿瘤显像的临床应用及研究进展[J].国际放射医学核医学杂志,2006,30(4):217-219. 被引量:3
  • 3E. GARCíA-GARAYOA,R. SCHIBLI,P.A. SCHUBIGER.Peptides radiolabeled with Re-186/188 and Tc-99m as potential diagnostic and therapeutic agents[J].Nuclear Science and Techniques,2007,18(2):88-100. 被引量:5
  • 4Shorr AF,Helman DL,Lettieri CJ,et al.Depreotide scanning in sarcoidosis:a pilot study.Chest,2004,126(4):1337-1343.
  • 5Van Den Bossche B,D' haeninck E,Bacher K,et al.Biodistribution and dosimetry of 99mTc-depreotide (P829) in patients suffering from breastcarcinoma CancerBiotherRadiopharm,2004,19(6):776-783.
  • 6Virgolini I,Leimer M,Handmaker H,et al.Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer,99mTc-P829.Cancer Res,1998,58 (9):1850-1859.
  • 7Watt HL,Kharmate G,Kumar U.Biology of somatostatin in breast cancer.Mol Cell Endocrinol,2008,286 (1-2):251-261.
  • 8LiuS.Bifunctional coupling agents for radiolabelin8 of biomolecules and target-specific delivery of metallic radionuclides.Adv Drug Deliv Rev,2008,60 (12):1347-1370.
  • 9Uehara T,Arano Y,Ono M,et al.The integrity of the disulfide bond in a cyclic somatostatin analog during 99mTc complexation reactions.Nucl Med Boil,1999,26 (8):883-89.
  • 10GULEWITSCH W,AMIRADZBI S.Ueber das Carnosin,eine neue organische Base des Fleischextractes[J].Dtsch Chem Ges,1900,33(2):344-379.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部